CD38 Deficiency Promotes Skeletal Muscle and Brown Adipose Tissue Energy Expenditure Through Activating NAD+-Sirt1-PGC1α Signaling Pathway.

Qi Ding,Ke Wen,Qian Li,Qi-Hang Zhao,Jia-Le Zhao,Yun-Fei Xiao,Xiao-Hui Guan,Mei-Xiu Jiang,Feng Zhang,Ling -Fang Wang

DOI: https://doi.org/10.1139/cjpp-2022-0454

2023-01-01

Canadian Journal of Physiology and Pharmacology

Abstract:Obesity is a metabolic syndrome characterized by abnormal lipid deposition and energy imbalance. CD38 is a single-chain transmembrane glycoprotein widely expressed in a variety of cell types. The roles of skeletal muscle and brown fat in CD38 deficiency under HFD-induced obesity remain unknown. In this study, we established obesity model with HFD and examined the changes in metabolites with metabonomics. Our results showed that CD38 expression was increased in muscle and brown fat after HFD treatment. Moreover, the results of metabonomics showed that CD38 deficiency significantly altered the metabolites in energy metabolism, cofactor generation, and redox homeostasis. Furthermore, CD38 deficiency reduced the expressions of NADPH oxidase 2 and FASN in mRNA level. We found that the expressions of Sirt1, Sirt3, and PGC1a were upregulated in CD38-deficient muscle tissue. In brown fat, the Sirt1-3, cell death inducing DFFA-like effector A, ELOVL3, and Dio2 expressions were increased in CD38-deficient mice. Our results showed the uncoupling protein 1 expression was upregulated. And NAD+ supplementation increased the expression of Sirt1 and PGC1a after palmitic acid treatment. Taken together, our results demonstrated that the protection of CD38 deficiency on HFD-induced obesity was related to the inhibition of oxidative stress and increasing energy expenditure via activating NAD+/Sirtuins signaling pathways in muscle and brown fat.